APOE genotype-specific differences in the innate immune response

Apolipoprotein-E protein is an endogenous immunomodulatory agent that affects both the innate and the adaptive immune responses. Since individuals with the APOE4 gene demonstrate worsened pathology and poorer outcomes in many neurological disorders, we examined isoform-specific differences in the response of microglia, the primary cellular component of the brain's innate immune response, in detail. Our data demonstrate that microglia derived from APOE4/4 targeted replacement mice demonstrate a pro-inflammatory phenotype that includes altered cell morphology, increased NO production associated with increased NOS2 mRNA levels, and higher pro-inflammatory cytokine production (TNFalpha, IL-6, IL12p40) compared to microglia derived from APOE3/3 targeted replacement mice. The effect is gene dose-dependent and increases with the number of APOE4 gene alleles. The APOE genotype-specific immune profile observed in the microglial immune response is also observed in the cortex of aged APOE3/3 and APOE4/4 mice treated with lipopolysacchride (LPS) and in peripheral (peritoneal) macrophages. To determine if APOE4's action resulted from an isoform-specific difference in effective levels of the apolipoproteins, we generated mice expressing only a single allele of APOE3. Immune-stimulated macrophages from APOE3/0 mice demonstrated an increased inflammatory response compared to APOE3/3 mice, but less than in APOE4/4 mice. These data suggest that inhibition of inflammation depends upon the dose of apoE3 protein available and that apoE4 protein may alter inflammation partly by dose effects and partly by being qualitatively different than apoE3. Overall, these data emphasize the important role of apolipoprotein E and of the APOE genotype on the immune responses that are evident in most, if not all, neurological disease.

[1]  S. Pizzo,et al.  Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides , 2001, Experimental Neurology.

[2]  D. Hume,et al.  CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. , 1999, The Biochemical journal.

[3]  S. Barger,et al.  Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E , 1997, Nature.

[4]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[5]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[6]  M. Vitek,et al.  COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. , 2007, Journal of neurotrauma.

[7]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[8]  Richard Graham Knowles,et al.  1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.

[9]  C. Colton,et al.  Microglial function in human APOE3 and APOE4 transgenic mice: altered arginine transport , 2003, Journal of Neuroimmunology.

[10]  C. Colton,et al.  APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress , 2002, Neurobiology of Aging.

[11]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Goetzl,et al.  Neuroimmune Networks: Physiology and Diseases , 1989 .

[13]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Christen,et al.  Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. , 2001, Brain research. Molecular brain research.

[15]  R. Mahley,et al.  Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. , 1980, The Journal of biological chemistry.

[16]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[17]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[18]  T. Montine,et al.  Neurotoxicity from innate immune response is greatest with targeted replacement of ε4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  W. Streit,et al.  The brain's immune system. , 1995, Scientific American.

[20]  C. Colton,et al.  Apolipoprotein E isoform mediated regulation of nitric oxide release. , 2002, Free radical biology & medicine.

[21]  V. Abraira,et al.  In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis , 1986, Brain Research.

[22]  A. Cardin,et al.  Suppression of lymphocyte activation by plasma lipoproteins. , 1983, Cancer research.

[23]  C. Colton,et al.  The APOE4 genotype alters the response of microglia and macrophages to 17β-estradiol , 2008, Neurobiology of Aging.

[24]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[25]  N. Relkin,et al.  Lower Cognitive Performance of Older Football Players Possessing Apolipoprotein E &egr;4 , 2000 .

[26]  N. Relkin,et al.  Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. , 1997, JAMA.

[27]  A. Roses.  Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain , 1997, Neurobiology of Disease.

[28]  C. Colton,et al.  Apolipoprotein‐E Allele‐Specific Regulation of Nitric Oxide Production , 2002, Annals of the New York Academy of Sciences.

[29]  D. Michaelson,et al.  APOE genotype is a major predictor of long-term progression of disability in MS , 2001, Neurology.

[30]  A. Minihane,et al.  Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression , 2007, Biochemical and biophysical research communications.

[31]  T. Montine,et al.  Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice , 2006 .

[32]  C. Colton,et al.  Androgen-mediated immune function is altered by the apolipoprotein E gene. , 2007, Endocrinology.

[33]  T. Morgan,et al.  Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. , 2007, Current Alzheimer research.

[34]  K.,et al.  Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. , 1982, The Journal of biological chemistry.

[35]  C. Colton,et al.  Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. , 1997, Biochemical and biophysical research communications.

[36]  D. Laskowitz,et al.  Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response , 2001, Journal of Neuroimmunology.

[37]  R. Elkon,et al.  Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade , 2005, Neurobiology of Disease.

[38]  D. Schmechel,et al.  Altered immune responses in apolipoprotein E-deficient mice. , 2000, Journal of lipid research.

[39]  C. Colton,et al.  Sex steroids, APOE genotype and the innate immune system , 2005, Neurobiology of Aging.

[40]  D. Bainbridge,et al.  Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. , 2001, The Journal of thoracic and cardiovascular surgery.

[41]  M. Netea,et al.  Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. , 1999, Journal of lipid research.

[42]  L. J. Eldik,et al.  A dual role for apolipoprotein E in neuroinflammation , 2007, Journal of Molecular Neuroscience.

[43]  Lars Lannfelt,et al.  HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy , 1998, Nature Medicine.

[44]  N. Nathoo,et al.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E , 2003, Molecular pathology : MP.

[45]  A. Daugherty,et al.  Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. , 1998, Journal of lipid research.

[46]  E. Corder,et al.  Genetic risk profiles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation , 2007, Neurobiology of Aging.